| Preoperative versus postoperative chemoradiotherapy for rectal cancer R Sauer, H Becker, W Hohenberger, C Rödel, C Wittekind, R Fietkau, ... New England Journal of Medicine 351 (17), 1731-1740, 2004 | 7230 | 2004 |
| 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer … JL Zamorano, P Lancellotti, D Rodriguez Munoz, V Aboyans, ... European heart journal 37 (36), 2768-2801, 2016 | 3186 | 2016 |
| Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up … R Sauer, T Liersch, S Merkel, R Fietkau, W Hohenberger, C Hess, ... J Clin oncol 30 (16), 1926-1933, 2012 | 2262 | 2012 |
| Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer C Rödel, P Martus, T Papadoupolos, L Füzesi, M Klimpfinger, ... Journal of clinical oncology 23 (34), 8688-8696, 2005 | 1440 | 2005 |
| ESPEN guidelines on enteral nutrition: non-surgical oncology J Arends, G Bodoky, F Bozzetti, K Fearon, M Muscaritoli, G Selga, ... Clinical nutrition 25 (2), 245-259, 2006 | 1025 | 2006 |
| Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial M Weller, N Butowski, DD Tran, LD Recht, M Lim, H Hirte, L Ashby, ... The Lancet Oncology 18 (10), 1373-1385, 2017 | 943 | 2017 |
| Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of … C Rödel, T Liersch, H Becker, R Fietkau, W Hohenberger, T Hothorn, ... The lancet oncology 13 (7), 679-687, 2012 | 852 | 2012 |
| Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final … C Rödel, U Graeven, R Fietkau, W Hohenberger, T Hothorn, D Arnold, ... The Lancet Oncology 16 (8), 979-989, 2015 | 744 | 2015 |
| 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving … V Strnad, OJ Ott, G Hildebrandt, D Kauer-Dorner, H Knauerhase, T Major, ... The Lancet 387 (10015), 229-238, 2016 | 730* | 2016 |
| Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies N Gökbuget, M Kneba, T Raff, H Trautmann, CR Bartram, R Arnold, ... Blood, The Journal of the American Society of Hematology 120 (9), 1868-1876, 2012 | 528 | 2012 |
| Tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: updated results of the CAO E Fokas, T Liersch, R Fietkau, W Hohenberger, T Beissbarth, C Hess, ... J Clin Oncol 32 (15), 1554-1562, 2014 | 472 | 2014 |
| Randomized phase II trial of chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO/ARO/AIO-12 E Fokas, M Allgäuer, B Polat, G Klautke, GG Grabenbauer, R Fietkau, ... Journal of Clinical Oncology 37 (34), 3212-3222, 2019 | 403 | 2019 |
| Neoadjuvant chemoradiation therapy with gemcitabine/cisplatin and surgery versus immediate surgery in resectable pancreatic cancer: results of the first prospective randomized … H Golcher, TB Brunner, H Witzigmann, L Marti, WO Bechstein, C Bruns, ... Strahlentherapie und Onkologie 191 (1), 7, 2015 | 316 | 2015 |
| Old and new facts about hyperthermia-induced modulations of the immune system B Frey, EM Weiss, Y Rubner, R Wunderlich, OJ Ott, R Sauer, R Fietkau, ... International Journal of Hyperthermia 28 (6), 528-542, 2012 | 307 | 2012 |
| Adjuvant vs. neoadjuvant radiochemotherapy for locally advanced rectal cancer: the German trial CAO/ARO/AIO‐94 R Sauer, R Fietkau, C Wittekind, C Rödel, P Martus, W Hohenberger, ... Colorectal Disease 5 (5), 406-415, 2003 | 305 | 2003 |
| German S3-guideline" Diagnosis and treatment of esophagogastric cancer" M Moehler, SE Al-Batran, T Andus, M Anthuber, J Arends, D Arnold, ... Zeitschrift fur Gastroenterologie 49 (4), 461-531, 2011 | 304 | 2011 |
| Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial D Hoelzer, J Walewski, H Döhner, A Viardot, W Hiddemann, ... Blood, The Journal of the American Society of Hematology 124 (26), 3870-3879, 2014 | 303 | 2014 |
| Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study (GIT NHL 02/96) P Koch, A Probst, WE Berdel, NA Willich, G Reinartz, J Brockmann, ... Journal of clinical oncology 23 (28), 7050-7059, 2005 | 296 | 2005 |
| Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery … C Polgár, OJ Ott, G Hildebrandt, D Kauer-Dorner, H Knauerhase, T Major, ... The Lancet Oncology 18 (2), 259-268, 2017 | 271 | 2017 |
| S3-guideline exocrine pancreatic cancer T Seufferlein, M Porzner, T Becker, V Budach, G Ceyhan, I Esposito, ... Zeitschrift fur Gastroenterologie 51 (12), 1395-1440, 2013 | 231 | 2013 |
